• The next generation of antimalarials

    Novartis has launched a programme to add novel treatments to its malaria pipeline and to complete clinical trials for two new candidates. So why are new antimalarials needed? Abi Millar...

  • Pharma Technology Focus – Issue 73

    In this issue: Major investment signals confidence in the search for new products developed from DNA found in soil, a medical milestone for cannabinoids in the US, streamlining clinical research,...

  • Pharma Technology Focus – Issue 72

    In this issue: Overcoming red tape in China, how to boost adoption of biosimilars in the US, a profile of global health research network TriNetX, unlocking cell-free protein synthesis, and...